12Reconstruction in the Cholesteatoma Ear

FDisease first, hearing second

Cholesteatoma is keratinising squamous epithelium that grows where it should not, and it does not behave politely. It erodes bone, harbours infection, and creeps into the recesses of the middle ear and mastoid — the attic, the facial recess, the sinus tympani — from which it readily recurs. The long process of the incus and the stapes superstructure sit directly in its path, which is why a cholesteatoma ear so often presents with both a conductive hearing loss and a chain that has already been partly dissolved. Faced with this, the surgeon’s priorities are fixed and ordered: eradicate the disease completely first, and only then ask how and when to rebuild the hearing [1994].

That ordering is not a stylistic preference; it is a safety rule. A prosthesis placed over residual cholesteatoma can bury active disease, hiding it behind a reconstruction and an intact-looking drum while it continues to erode toward the labyrinth, the facial nerve and the dura. The reconstruction is therefore always subordinate to clearance. In the cholesteatoma ear, more than anywhere else in ossiculoplasty, the question is less “which prosthesis?” and more “is the ear safe and ready to receive one yet?” — and the answer to that question is what drives the whole strategy of staging and surveillance that this module is about.

FThe paradox of the cholesteatoma ear

It is tempting to assume that the most destructive disease must give the worst reconstructive bed. The cholesteatoma ear turns that intuition on its head. Compared with the chronically inflamed, atelectatic, fibrotic ear of mucosal chronic otitis media — in which irreversible mucosal change and a collapsed, airless middle ear are the leading causes of late ossiculoplasty failure — a cholesteatoma ear that has been completely cleared can actually heal remarkably well [2005]. Once the sac and its matrix are entirely gone, the denuded promontory re-mucosalises, the ear dries out, and the middle-ear cleft can re-aerate into a clean, ventilated space.

That is the paradox: provided the disease is eradicated, the cholesteatoma ear offers a more favourable surgical field for ossicular reconstruction than many “simpler” chronically discharging ears— a dry environment with fresh mucosa that supports stable prosthesis placement and acceptable hearing [2015]. The entire word that carries the weight in that sentence, though, is completely. The favourable bed appears only on the far side of confident clearance and healing. Where clearance is uncertain or the mucosa is still denuded and oedematous, the same ear is hostile, and reconstructing into it at that moment squanders the advantage. This is precisely why timing — not material choice — dominates strategy here.

TWhen to stage and when to do it in one sitting

The central decision in the cholesteatoma ear is whether to reconstruct the chain at the same operation as clearance (single-stage) or to defer it to a planned later operation (staged). Two separate considerations drive that choice, and it helps to keep them apart.

• Certainty of disease clearance.If the surgeon cannot be confident that all matrix has been removed — extensive disease, a difficult sinus tympani, a cell tract that could not be fully followed — a planned second look lets the recesses of recurrence be re-inspected before the chain is committed. Doubt about clearance is itself an indication to stage [2016].
• State of the reconstructive bed. A denuded, oedematous, freshly-drilled middle ear is a poor place to seat a prosthesis. Staging lets the mucosa re-epithelialise, the ear prove dry, and the cleft re-aerate, so that the reconstruction is placed into a healed, ventilated pocket rather than an inflamed one [2005].

These factors map directly onto the prognostic indices used throughout ossiculoplasty: the OOPS index weights absent malleus, fibrotic mucosa, drainage, canal-wall-down surgery and revision — the very features that cluster in the cholesteatoma ear and that staging is designed to convert from adverse to favourable before the prosthesis goes in [2001]. The corollary is just as important: a fully cleared ear with healthy mucosa, an intact mobile stapes superstructure and good aeration needs no staging. There, a single-stage PORP onto the stapes head is appropriate, avoids a second anaesthetic, and spares the patient the interval hearing loss and cost of a routine re-operation [2016].

TMaintaining the space and choosing the prosthesis

When the decision is to stage, the first operation does more than clear disease: it prepares the ear to be rebuilt later. The key manoeuvre is to preserve a middle-ear air space. A sheet of Silastic laid over the promontory and into the eustachian-tube orifice keeps the healing mucosal surfaces apart, discourages the adhesions and fibrous obliteration that would otherwise tether and stiffen the future reconstruction, and maintains an aerated pocket for the prosthesis to live and move in [2005]. The acoustic logic is the same one that governs all cavity reconstruction: an inert strut can only transmit sound if it is suspended in an aerated space and the round window can move out of phase with the oval window [1998].

At the reconstructive sitting — whether that is the same operation or the second stage — prosthesis choice follows the surviving anatomy, exactly as in any ossiculoplasty, but with two cholesteatoma-specific cautions.

• Match the prosthesis to the stapes.A mobile stapes superstructure takes a partial ossicular replacement prosthesis (PORP) onto the stapes head; an absent superstructure with a mobile footplate needs a total ossicular replacement prosthesis (TORP) onto the footplate. TORP results depend heavily on the healed, aerated pocket beneath the drum — one more reason these chains are often staged [2001].
• Be wary of autograft ossicles.Reusing the patient’s own eroded incus risks re-implanting microscopic cholesteatoma matrix and is unwise where clearance is uncertain; cartilage, titanium or hydroxyapatite prostheses avoid that hazard, and a cartilage interposition or shield doubles as a guard against extrusion through a healing drum [2015].

CSurveillance: the second look and its imaging rival

Staging in cholesteatoma is not only a reconstructive tactic; it is, classically, a surveillance one. The planned second-look operation was conceived to detect residual disease in the recesses of canal-wall-up ears before it could re-grow unseen, and the reconstruction was conveniently performed at the same sitting once the ear was confirmed clear. For decades a routine second look was standard in intact-canal-wall cholesteatoma surgery. That position has softened. Modern series show that recidivism after canal-wall-up surgery is relatively low, and that the cost of re-operating on every patient to find disease in a minority is hard to justify; the second look is now best individualised rather than performed universally [2016].

What changed the calculus is imaging. Non-echo-planar diffusion-weighted MRI (non-EPI DWI) identifies keratin with high pooled sensitivity and specificity, and can detect residual or recurrent cholesteatoma non-invasively, sparing many patients a purely diagnostic re-operation [2016]. Its honest limitation is resolution: lesions below roughly three millimetres can be missed, so a negative scan does not abolish the need for continued clinical and otoscopic follow-up. The practical consequence for reconstruction is that the surgeon can oftendecouplethe hearing operation from disease surveillance — reconstruct in a single stage in a confidently cleared favourable ear and follow up with DWI, reserving the planned second look for ears where clearance was genuinely doubtful or anatomy hides the recesses [2016, 2016].

CPutting timing and technique together

A defensible policy for the cholesteatoma ear can be stated in a few sentences. First, clear the disease completely; never trade eradication for a hearing result, and never bury a prosthesis over doubtful matrix. Second, read the ear at the end of clearance: if the ear is confidently clear, the mucosa healthy and the stapes mobile, reconstruct in a single stage with a PORP or TORP to match the chain. Third, if clearance is uncertain or the bed is hostile, stage — preserve an aerated space with Silastic, let the ear heal and prove dry, and rebuild at a second sitting that doubles as a check for residual disease [2001, 2005].

Finally, let surveillance, not ritual, decide who returns to theatre. Use non-EPI DWI to follow the confidently cleared ear, and reserve the planned second look for the ear in which doubt or difficult anatomy genuinely warrants re-exploration [2016, 2016]. Counsel patients accordingly: that a cholesteatoma ear, once truly cleared, can hear well; that the staging interval is an investment in both safety and a stable reconstruction rather than a delay for its own sake; and that hearing rehabilitation always travels behind, and at the pace set by, the control of the disease. Get the timing right and the technical reconstruction — the same prostheses and principles used everywhere else — will do its job [1994, 2015].